Patent · US Expired

Papillomavirus truncated L1 protein and fusion protein constructs

US7182947B2 · kind B2 · utility

3Cited by
5References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 4, 2003
Grant dateFeb 27, 2007
Priority date
Expiry dateFeb 27, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/20022
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.